Advisors Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,644
| Closed | -$55K | – | 1430 |
|
|
2023
Q1 | $55K | Sell |
9,644
-326
| -3% | -$1.86K | ﹤0.01% | 1295 |
|
|
2022
Q4 | $101K | Sell |
9,970
-22,843
| -70% | -$230K | ﹤0.01% | 1245 |
|
|
2022
Q3 | $735K | Sell |
32,813
-746
| -2% | -$16.7K | 0.02% | 826 |
|
|
2022
Q2 | $832K | Sell |
33,559
-6,183
| -16% | -$153K | 0.02% | 805 |
|
|
2022
Q1 | $1.54M | Sell |
39,742
-3,304
| -8% | -$128K | 0.02% | 670 |
|
|
2021
Q4 | $2.52M | Buy |
43,046
+1,678
| +4% | +$98.2K | 0.04% | 530 |
|
|
2021
Q3 | $2.45M | Buy |
41,368
+5,902
| +17% | +$350K | 0.04% | 532 |
|
|
2021
Q2 | $3.08M | Buy |
35,466
+5,796
| +20% | +$503K | 0.05% | 445 |
|
|
2021
Q1 | $2.45M | Buy |
29,670
+12,128
| +69% | +$1,000K | 0.04% | 517 |
|
|
2020
Q4 | $1.6M | Buy |
17,542
+11,109
| +173% | +$1.01M | 0.03% | 640 |
|
|
2020
Q3 | $257K | Buy |
6,433
+2,980
| +86% | +$119K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $118K | Buy |
+3,453
| New | +$118K | ﹤0.01% | 1268 |
|